Sign up to save your podcasts
Or
Share Improving Outcomes in Patients with RVO: Tailoring Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Improving Outcomes in Patients with RVO: Tailoring Treatment
CME credits: 1.00
Valid until: 14-11-2024
Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-in-patients-with-rvo-tailoring-treatment/16626/
Dr. Carl Danzig, Director of Vitreoretinal Services and Retina Clinical Research of Rand Eye Institute in Deerfield Beach, Florida, and Dr. Arshad Khanani, Clinical Associate Professor at the University of Nevada in Reno, Nevada, will present key data about anti-VEGF therapies for retinal vein occlusion (RVO). Join the discussion on developing treatment protocols that use current therapies most effectively to improve outcomes and individualized treatment protocols for patients who are nonresponsive to first-line therapies and who require chronic treatment for macular edema.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 14-11-2024
Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-in-patients-with-rvo-tailoring-treatment/16626/
Dr. Carl Danzig, Director of Vitreoretinal Services and Retina Clinical Research of Rand Eye Institute in Deerfield Beach, Florida, and Dr. Arshad Khanani, Clinical Associate Professor at the University of Nevada in Reno, Nevada, will present key data about anti-VEGF therapies for retinal vein occlusion (RVO). Join the discussion on developing treatment protocols that use current therapies most effectively to improve outcomes and individualized treatment protocols for patients who are nonresponsive to first-line therapies and who require chronic treatment for macular edema.
=